Neostigmine Methylsulfate Injection, Solution
Product Images NDC 76045-214

11 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 76045-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Neo0i 0004 01)

Structural Formula (Neo0i 0004 01)
Chemical structure of Neostigmine Methylsulfate, showing a benzene ring with a quaternary ammonium group, a methyl sulfate counterion, and a carbamate functional group attached to the aromatic ring.*
FDA Label Image

Figure 1 (Neo0i 0004 02)

Figure 1 (Neo0i 0004 02)
An instructional diagram showing components of a prefilled syringe including plunger rod, syringe barrel with label (marked Do not remove), syringe tip cap, and luer lock collar (marked Do not remove). The syringe is depicted inside an outer package.*
FDA Label Image

Figure 2 (Neo0i 0004 03)

Figure 2 (Neo0i 0004 03)
An instructional illustration showing hands opening a sealed blister pack containing a prefilled injection device consistent with intravenous use. The image demonstrates the step of peeling back the protective film to access the injection device, likely relating to Neostigmine Methylsulfate injection preparation or administration.*
FDA Label Image

Figure 3 (Neo0i 0004 04)

Figure 3 (Neo0i 0004 04)
An instructional line drawing showing a pair of hands removing or breaking the cap off a small cylindrical vial or ampule, illustrating the proper way to open the vial for use.*
FDA Label Image

Fresenius Kabi Logo (Neo0i 0004 05)

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Neostigmine Methylsulfate Injection, USP, showing 3 mg per 3 mL (1 mg per mL) in a single-dose prefilled syringe for intravenous use. The label includes a dosing scale from 0.5 mL to 3 mL, the Fresenius Kabi manufacturer name, and a barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Neostigmine Methylsulfate Injection USP 3 mg per 3 mL (1 mg per mL) in a 3 mL single-dose prefilled syringe. The label includes directions for intravenous use, storage temperature (20° to 25°C), and handling instructions. The product is labeled by Fresenius Kabi USA, LLC with NDC 76045-383-13.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Packaging label for Neostigmine Methylsulfate Injection, USP 1 mg/mL (3 mg per 3 mL) solution for intravenous use. The label indicates single-dose prefilled syringes, containing 10 syringes of 3 mL each. It includes manufacturer details: Fresenius Kabi USA, LLC, with storage instructions and warnings about use on a sterile field. NDC 76045-383-30 is visible.*
FDA Label Image

Package Label – Principal Display – Neostigmine 3 mL Syringe Label (Neo0i 0004 09)

Package Label – Principal Display – Neostigmine 3 mL Syringe Label (Neo0i 0004 09)
Label for Neostigmine Methylsulfate Injection, USP, 3 mg per 3 mL (1 mg per mL) single-dose prefilled syringe for intravenous use. The label includes a volume scale from 0.5 mL to 3 mL, a barcode, RFID indicator, and the manufacturer name Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label – Principal Display – Neostigmine 3 mL Syringe Blister Label (Neo0i 0004 10)

Package Label – Principal Display – Neostigmine 3 mL Syringe Blister Label (Neo0i 0004 10)
Neostigmine Methylsulfate Injection, USP 3 mg per 3 mL (1 mg per mL) in a 3 mL single-dose prefilled syringe. The label specifies for intravenous use only and is labeled by Fresenius Kabi USA, LLC. Storage instructions and usual dosage information are indicated, along with barcode and lot number details.*
FDA Label Image

Package Label – Principal Display – Neostigmine 3 mL Syringe Carton Label (Neo0i 0004 11)

Package Label – Principal Display – Neostigmine 3 mL Syringe Carton Label (Neo0i 0004 11)
Carton label for Neostigmine Methylsulfate Injection, USP 3 mg per 3 mL (1 mg per mL) by Fresenius Kabi USA, LLC. The label states intravenous use only and contains 10 x 3 mL single-dose prefilled syringes. Directions include discarding unused portion and storage at controlled room temperature. The label includes NDC 76045-214-30 and warnings about syringe placement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.